Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Threshold’s cancer drug gets Orphan Drug designation
Proactive Investors
Saturday, March 17, 2012 - 11:23am
tags:
Threshold Pharmaceuticals, TH-302, sarcoma
SOHM, Inc. Entering the Huge USA Generic Pharmaceutical Market
MarketWire
Saturday, March 17, 2012 - 11:21am
tags:
SOHM Inc, generics
Experts question Merck drug
Yahoo/Investors Business Daily
Saturday, March 17, 2012 - 10:54am
tags:
Merck, Taltorvic, sarcoma
UTHR Files Suit vs. Sandoz
Yahoo/Zacks
Saturday, March 17, 2012 - 10:53am
tags:
United Therapeutics, Sandoz, Novartis, generics, Remodulin
St. Louis-based Carey, Danis & Lowe Files Federal Suit in Illinois Against the Maker of Zoloft
Yahoo/BusinessWire
Saturday, March 17, 2012 - 10:52am
tags:
Zoloft, Pfizer
Johnson & Johnson Passes This Key Test
Motley Fool
Saturday, March 17, 2012 - 10:50am
tags:
JNJ
4-Star Stocks Poised to Pop: Eli Lilly
Motley Fool
Saturday, March 17, 2012 - 10:50am
tags:
Eli Lilly
Putting Mylan’s Earnings Quality Under the Microscope: Greenberg
CNBC
Saturday, March 17, 2012 - 10:49am
tags:
Mylan
7 Biotech Stocks Being Snapped Up By Insiders
Seeking Alpha
Saturday, March 17, 2012 - 10:46am
tags:
Agenus, China Biologic, Halozyme, Incyte, NuPathe, QLT, Seattle Genetics
Agenus Continues to Outperform
Seeking Alpha
Saturday, March 17, 2012 - 10:42am
tags:
Agenus, vaccines, cancer vaccines
Neurocrine edges higher on analyst comments
Yahoo/AP
Saturday, March 17, 2012 - 10:40am
tags:
Neurocrine Biosciences, Elagolix, endometriosis
Drug Pricing Takes This Biotech on a Rollercoaster
Motley Fool
Saturday, March 17, 2012 - 10:38am
tags:
InterMune, idiopathic pulmonary fibrosis, Esbriet
Keryx, AEterna rally ahead of study results
MarketWatch
Saturday, March 17, 2012 - 10:36am
tags:
Keryx, Aeterna Zentaris
Alexion, 2 Others Top-Rated Among Medical Stocks
Investors.com
Saturday, March 17, 2012 - 10:36am
tags:
Alexion, Questcor Pharmaceuticals, Celgene
Early Submission = 60% Pop
Motley Fool
Saturday, March 17, 2012 - 10:34am
tags:
Endocyte, EC145, ovarian cancer
4-Star Stocks Poised to Pop: Amgen
Motley Fool
Saturday, March 17, 2012 - 10:33am
tags:
Amgen
Miles White, Abbott execs see pay drop
Chicago Business, IL
Friday, March 16, 2012 - 11:44am
tags:
Abbott Laboratories, Miles White, executive pay
What Stresses Some Pharma Employees The Most
Pharmalot
Friday, March 16, 2012 - 11:43am
tags:
drug manufacturing, pharma employees
Valeant's Latin American Venture
Yahoo/Zacks
Friday, March 16, 2012 - 11:42am
tags:
Valeant Pharmaceuticals, M&A, Brazil, Latin America, Pele Nova Biotecnologia, Regederm
Amarin jumps 8% on patent progress, takeover talk
Marketwatch
Friday, March 16, 2012 - 11:40am
tags:
Amarin, M&A, AMR-101

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.